A Single-Dose Pharmacokinetic Study of Lepodisiran in Participants with Varying Degrees of Liver Impairment and Participants with Normal Liver Function
This clinical trial is studying an experimental medicine called lepodisiran. The liver acts as a natural filter, breaking down medicines and clearing them from the bloodstream. When a person has liver problems, medicines can sometimes build up or clear out at different speeds. In this study, researchers want to see how the body absorbs, breaks down, and removes a single dose of lepodisiran. They will compare results between people with healthy livers and people with mild, moderate, or severe liver disease. Participants will receive one dose of the medicine and have regular blood tests and health checks. This information will help doctors understand whether future doses need to be adjusted for people with liver conditions. The study is open to adults aged 18 and over, and taking part is completely voluntary.
En un coup d'œil
De quoi parle cette étude ?
When new medicines are created, scientists need to understand how they travel through the human body. This includes checking how the drug is absorbed, how it breaks down, and how it leaves the system. This early trial is testing an experimental medicine named lepodisiran to see how the body processes it.
The liver plays a vital role in processing many medicines. If someone has a liver condition, their liver may not process medicines in the normal way. This could mean a drug stays in the blood for longer, which might increase the risk of side effects. To make sure lepodisiran is safe for everyone, researchers need to compare how it behaves in people with healthy livers versus those with liver damage.
By comparing volunteers with normal liver function to those with mild, moderate, or severe liver problems, doctors can gather key safety details. The findings will help doctors decide whether people with liver conditions will need a lower dose or a different schedule if this medicine is approved in the future.
Points clés
- Tests how the body handles a single dose of the medicine lepodisiran.
- Compares adults with healthy livers to those with mild, moderate, or severe liver conditions.
- Helps doctors calculate safe, accurate doses for future patients with liver disease.
- Includes health checks and regular blood tests to track drug levels.
- Taking part is voluntary, and you are free to stop at any time.
Qui peut être éligible ?
This trial is open to adults aged 18 and older. Both men and women may be able to join. The researchers are looking for two main groups of volunteers: people with healthy livers and people who have been diagnosed with mild, moderate, or severe liver conditions.
To ensure it is safe for you to take part, the study team will carry out health checks and blood tests. These tests will confirm how well your liver and kidneys are working and make sure you do not have any other medical conditions that would make taking part unsafe.
You may not be eligible if you take certain other medicines that could interfere with lepodisiran, or if you have recent serious health issues. The study doctors will review your complete medical history before you join.
Cet étude pourrait-elle vous convenir ?
Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.
- J'ai au moins 18 ans.
- I have either normal liver function or a known mild, moderate, or severe liver condition.
- I am willing to attend clinic visits and have regular blood tests.
- I am able to give informed consent to take part.
- I can provide details of any regular medications I take.
En quoi consiste la participation ?
Taking part involves receiving a single dose of lepodisiran. Before you receive the medicine, you will attend a screening appointment to check your overall health. This usually includes blood tests, urine tests, and checks of your heart and blood pressure. You may need to stay at the clinic or visit regularly over several days or weeks so staff can take blood samples to measure medicine levels. Total time in the study will be discussed with you beforehand, and staff will monitor you closely for any changes in your health.
Risques et avantages potentiels
Emplacements (1)
- —Non vérifiéHongrie
Questions fréquentes
Quel est l'objectif principal de cette étude ?
The goal is to see how different levels of liver health affect the way the body processes a single dose of lepodisiran.
Will this medicine treat my liver disease?
No. This study is not designed to treat or cure liver disease. It only looks at how the body handles the medicine.
Comment le médicament est-il administré ?
Lepodisiran is given as a single dose during the trial, and the study team will guide you on how it is administered.
Do I have to pay to take part?
No, you do not pay for the study medicine or tests. Travel costs and time are often reimbursed by the study team.
Puis-je quitter l'étude si je change d'avis ?
Yes. You are free to withdraw from the trial at any time, for any reason, without your normal medical care being affected.
Comment en savoir plus
Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.
Intéressé à participer ?
Discussion
Discussion communautaire
Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.